Developing RNA-based treatments for rare diseases
Israel’s Skip Therapeutics is partnering with Sheba Medical Center to develop ASO-based (short RNA sequences) treatments for rare genetic diseases. Skip’s ASOs (Antisense Oligonucleotide) aim to restore the function of mutated genes in genetic disorders.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink